Benitec Biopharma Ltd (BLT)-Financial and Strategic SWOT Analysis Review

Benitec Biopharma Ltd (BLT)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH61680FSA
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Benitec Biopharma Ltd (BLT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Benitec Biopharma Ltd (Benitec), is a research based clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based therapeutics for various conditions such as hepatitis B, wet age related macular degeneration and OPMD. The company also licenses its ddRNAi to various biopharmaceutical companies for the development of drugs for the treatment of conditions such as HIV/AIDS, Huntington's disease, chronic neuropathic pain, cancer immunotherapy and retinitis. The company has its research laboratories in Hayward, California, the US. Benitec is headquartered in Sydney, New South Wales, Australia.

Benitec Biopharma Ltd Key Recent Developments

Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross

Aug 10, 2016: Benitec announces restructuring of Senior Executive team

Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received

May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

Apr 29, 2016: Benitec Biopharma: Quarterly Cash Flow-Appendix 4C

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Benitec Biopharma Ltd-Key Facts 6

Benitec Biopharma Ltd-Key Employees 7

Benitec Biopharma Ltd-Key Employee Biographies 8

Benitec Biopharma Ltd-Major Products and Services 9

Benitec Biopharma Ltd-Pharmaceutical Pipeline Products Data 10

Benitec Biopharma Ltd, Pipeline Products by Therapy Area 10

Benitec Biopharma Ltd, Pipeline Products by Development Phase 11

Benitec Biopharma Ltd-History 13

Benitec Biopharma Ltd-Company Statement 16

Benitec Biopharma Ltd-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Benitec Biopharma Ltd-Business Description 18

Benitec Biopharma Ltd-Corporate Strategy 19

Benitec Biopharma Ltd-SWOT Analysis 20

SWOT Analysis-Overview 20

Benitec Biopharma Ltd-Strengths 20

Benitec Biopharma Ltd-Weaknesses 21

Benitec Biopharma Ltd-Opportunities 22

Benitec Biopharma Ltd-Threats 23

Benitec Biopharma Ltd-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Benitec Biopharma Ltd, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Aug 16, 2016: Benitec Announces Appointment Of New Director And Chair Of Audit Committee And Retirement Of Director, Mr Iain Ross 34

Aug 10, 2016: Benitec announces restructuring of Senior Executive team 35

Jun 16, 2016: Benite Biopharma: Federal R&D Tax Credit Received 36

May 24, 2016: Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016 37

Apr 29, 2016: Benitec Biopharma: Quarterly Cash Flow-Appendix 4C 38

Apr 06, 2016: CSHL Reports That the U.S. Patent Office Denies All 4 Petitions Filed by Benitec Biopharma against CSHL's shRNA Patents 39

Feb 26, 2016: Benitec Biopharma : Interim Report for the Half Year Ended December 31, 2015 40

Dec 08, 2015: Greg West, Benitec's Chief Financial Officer and Company Secretary, Named Interim Chief Executive Officer 41

Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory 42

Oct 19, 2015: Benitec Forms Hepatology Clinical Advisory Board 43

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

Benitec Biopharma Ltd, Pipeline Products by Therapy Area 10

Benitec Biopharma Ltd, Pipeline Products by Development Phase 11

Benitec Biopharma Ltd, Performance Chart (2012-2016) 28

Benitec Biopharma Ltd, Ratio Charts 30

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 32

List of Tables

Benitec Biopharma Ltd, Key Facts 6

Benitec Biopharma Ltd, Key Employees 7

Benitec Biopharma Ltd, Key Employee Biographies 8

Benitec Biopharma Ltd, Major Products and Services 9

Benitec Biopharma Ltd, Number of Pipeline Products by Therapy Area 10

Benitec Biopharma Ltd, Number of Pipeline Products by Development Stage 11

Benitec Biopharma Ltd, Pipeline Products By Therapy Area and Development Phase 12

Benitec Biopharma Ltd, History 13

Benitec Biopharma Ltd, Other Locations 17

Benitec Biopharma Ltd, Subsidiaries 17

Benitec Biopharma Ltd, Key Competitors 24

Benitec Biopharma Ltd, Ratios based on current share price 25

Benitec Biopharma Ltd, Annual Ratios 26

Benitec Biopharma Ltd (Cont...1), Annual Ratios 27

Benitec Biopharma Ltd, Interim Ratios 29

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Benitec Biopharma Ltd, Recent Deals Summary 33

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 46

Efficiency Ratios 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Benitec Biopharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8003
Site License
USD 250 INR 16005
Corporate User License
USD 375 INR 24008

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com